Dynatrace, Inc <DT.N>: Wedbush Assumes Coverage With Neutral vs Outperform Rating; Price Target $54
DT•Related News
Medicus Pharma issues 8,529,412 restricted shares in lieu of $1.45 million cash bonuses
MDCX•
Tempest Therapeutics prices $2.5 million private placement at $0.81 per share
TPST•
Wingstop Inc. <WING.O>: TD Cowen cuts target price to $120 from $160
WING•
Prelude Therapeutics to join H.C. Wainwright Global Investment Conference fireside chat
PRLD•
Charles River Labs to present at Morgan Stanley global healthcare conference
CRL•